Mr. Chair, thank you very much.
Ladies and gentlemen members of the committee, good afternoon.
It is my pleasure to appear before you today on behalf of Canada's International Development Research Centre, better known by its acronym, IDRC. IDRC welcomes the opportunity to participate in the committee's study on countries of focus for Canada's bilateral development assistance, as well as the priority sectoral themes.
Today I will address three main points. The first is focus—both how it and flexibility are important. Second is the impact of our work research that often goes beyond only one country. Third is the power of working thematically across a number of countries.
Before I get into these remarks, however, I thought it might be helpful for me to share some background information about IDRC that is relevant to today's discussion.
IDRC was founded as a crown corporation in 1970 through the International Development Research Centre Act. This legislation directs IDRC “to initiate, encourage, support and conduct research into the problems of the development regions of the world and into the means for applying and adapting scientific, technical and other knowledge to the economic and social advancement of those regions.”
IDRC's value proposition, when it comes to Canada's international development mandate, is multi-faceted and is founded on the knowledge and networks of our expert staff, achieving impacts of scale, and building the self-reliance of countries. It is also founded on our accountability to Parliament, to our board, and to our donor partners. We have been an asset for Canada's broader foreign affairs family through our 46 years of supporting innovative research, and through our engagement with a large global network of actors that helps Canada deliver on its international development priority at the same time as it builds important relationships for Canada.
What do we do? Very simply, we provide funds to research institutions driving global change. Our grantees are problem-solvers. Our model of working with them is a theme-based approach. In particular, we focus on three problematic areas: agriculture and environment, inclusive economies, and technology and innovation. Within these three areas we have a number of programs, all of which are aligned with Canadian government priorities, as well as the needs of developing countries.
In short, IDRC invests in knowledge, innovation, and solutions to improve lives and livelihoods in the developing world.
Let me now turn to the three points I introduced a moment ago.
First is the question of the focus of our work and where to work. Let's take the Ebola crisis as an example. West Africa experienced, as we all know, the largest-ever Ebola outbreak in 2014-15, mainly in Sierra Leone, Liberia, and Guinea. Canadian partners, including IDRC, were at the forefront of developing and running trials of the Canadian Ebola vaccine that saved lives and helped stop the spread of the disease. That is a major success story.
However, the less-told story is the extent to which weak health systems are at the core of why these outbreaks become crises in the first place. We see this through our approach to working on topics collaboratively and across countries. In the late nineties we funded research and capacity-building at the Lacor Hospital in northern Uganda in the region of Gulu, when an Ebola outbreak happened in 2000. These investments meant that health care workers knew exactly what to do when an outbreak of unknown origin happened. The response was driven by local teams and was extremely effective, limiting the outbreak to barely more than 400 persons.
It is important to be in the right place at the right time. But it is also important to take into consideration the long-term investment in research that doesn't deliver instantaneously. We cannot only answer crises; we also need to prevent them through long-term investment.
Second, the result of science and research extends beyond the borders of a country. When Canada, the United States, and Mexico agreed to eliminate DDT, a toxic chemical insecticide used to combat malaria, that was in the context of the ratification of the parallel agreement of the North American Free Trade Agreement. It was very easy for Canada and the U.S. since we had not used the toxic chemical for years, but Mexico was still using it to control malaria, so they faced the greatest challenge.
We worked with the Mexican government at that time to develop a new approach that could be used to control malaria without DDT. The approach was so effective in Mexico, limiting the cases to almost zero, that it was and is now being applied in many other countries in Central America. This example is an illustration of how a solution developed in one place can be replicated across many countries.
Third, I would like to share with you the power of working on a theme across a number of countries simultaneously.
For example, the Canadian International Food Security Research Fund is an initiative launched in 2009 by IDRC and the department that has now become Global Affairs Canada. The fund has so far supported 39 projects between Canada and developing country institutions in 24 countries to improve food security. That initiative does not target any particular country, but recognizes the importance of flexibility in research.
So far, the research projects supported by this fund have benefited more than 383,000 farmers in Africa, Asia, Latin America, and the Caribbean. Examples of the more than 130 innovations that have been tested include a five-disease-in-one vaccine for livestock that allows farmers to protect their livestock affordably without vaccines that need a cold chain and booster shots. It was very effective.
This program is also supporting researchers who are improving the resilience and nutritional content of pulse crops that include lentils, beans, and chickpeas, which are affordable, nutritious, and a high source of protein for populations across the developing world.
These three points that I made demonstrate IDRC's systematic approach providing the opportunity for a research-focused organization to focus its efforts and also to remain flexible within the mandate on which we are delivering.
I would like to conclude with three brief points about metrics, time, and partnerships.
Metrics allow you to measure performance through the life of a project when initiatives produce not only an outcome but also early and intermediate outcomes. It's important that when we give money, we don't wait a decade before a result happens, even when it's researched and takes time. We have a duty to measure ourselves to keep the work on track and also learn how to do course corrections and adjust.
Second, it takes time for long-term investment to pay off. Research can take up to 10 or 15 years. The Ebola vaccine that was developed by our researcher, Gary Kobinger, at the Public Health Agency of Canada in Winnipeg, started about 15 years ago. The success was present in 2015 because this investment was made and was followed through on.
We see the benefit of time in each of the examples I've provided today. DDT is the same. It took 10 years of investment before we came to have Central America free from it.
Food security is an ongoing behaviour. Our model at the IDRC has been proven successful and has attracted many partnerships, which is my third point.
One of the single most powerful demonstrations of this success is that other Canadian and international partners are joining us and empowering our work with funds to deliver on programs that carry with them Canadian values and priorities.
In fact, between 2010 and 2015, IDRC supplemented our parliamentary appropriation with more than $350 million from donors including the Bill and Melinda Gates Foundation, the William and Flora Hewlett Foundation, and governments in the U.K., Australia and Norway.
In conclusion, I believe that IDRC's experience across program areas and priority countries positions it to be an effective tool for the Canadian government. Our model is both effective and adaptable, and we look forward to helping the Canadian government deliver on its international development mandate.
Honourable members of the committee, I hope you have found these remarks informative. We have made available copies of our Strategic Plan 2015-2020 for your reference.
This strategic plan is not a glossy brochure; it's not the short summary. It is the strategic plan of IDRC that talks about knowledge and innovation solutions that measure impact at scale, support leadership of youth and established researchers, and work in partnership on substance and on funding.
I thank you for your attention and for having given IDRC and myself the opportunity to speak today. I will be more than happy to answer your questions.
Thank you very much.